Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
Holdings in Q3 2025
Holdings as of Sep 30, 2025, filed Nov 14, 2025. Long positions only; changes compare share counts with Q2 2025.
- Positions
- 43
- −12 vs. Q2 2025
- Portfolio value
- $439.4M
- −$59.4M (−11.9%) vs. Q2 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. | COM | 3,204,184 | $126.1M | 28.7% | +1,461,282+83.8% | Added | History |
| CGONCG Oncology, Inc. | COM | 1,600,899 | $64.5M | 14.7% | +100,957+6.7% | Added | History |
| MDTMedtronic plc | Stock | 190,600 | $18.2M | 4.1% | +190,600 | New | History |
| BSXBoston Scientific Corp | Stock | 164,300 | $16.0M | 3.7% | −157,500−48.9% | Reduced | History |
| ORKAOruka Therapeutics, Inc. | COM | 660,424 | $12.7M | 2.9% | +308,300+87.6% | Added | History |
| BMYBristol Myers Squibb Co | Stock | 257,600 | $11.6M | 2.6% | +257,600 | New | History |
| NTRANatera, Inc. | COM | 70,400 | $11.3M | 2.6% | −128,900−64.7% | Reduced | History |
| DHRDanaher Corp | Stock | 54,700 | $10.8M | 2.5% | −35,000−39.0% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 510,000 | $10.3M | 2.3% | −179,500−26.0% | Reduced | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 2,994,033 | $10.3M | 2.3% | +1,135,437+61.1% | Added | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,127,186 | $9.73M | 2.2% | 00.0% | Unchanged | History |
| PFEPfizer Inc | Stock | 366,400 | $9.34M | 2.1% | +366,400 | New | History |
| TMOThermo Fisher Scientific Inc. | Stock | 18,900 | $9.17M | 2.1% | −10,700−36.1% | Reduced | History |
| CNTXContext Therapeutics Inc. | COM | 8,981,855 | $8.70M | 2.0% | +1,504,600+20.1% | Added | History |
| GMABGenmab A/S | SPONSORED ADS | 248,100 | $7.61M | 1.7% | −401,900−61.8% | Reduced | History |
| MTSRMetsera, Inc. | COM | 140,500 | $7.35M | 1.7% | +140,500 | New | History |
| UNHUnitedHealth Group Inc | Stock | 17,800 | $6.15M | 1.4% | −14,200−44.4% | Reduced | History |
| ARVNArvinas, Inc. | COM | 698,363 | $5.95M | 1.4% | +455,201+187.2% | Added | History |
| CORCencora, Inc. | Stock | 19,000 | $5.94M | 1.4% | −13,800−42.1% | Reduced | History |
| EHCEncompass Health Corp | COM | 41,900 | $5.32M | 1.2% | −32,100−43.4% | Reduced | History |
| JNJJohnson & Johnson | Stock | 26,800 | $4.97M | 1.1% | +26,800 | New | History |
| CICigna Group | Stock | 16,600 | $4.78M | 1.1% | +16,600 | New | History |
| ABBVAbbVie Inc. | Stock | 19,800 | $4.58M | 1.0% | +19,800 | New | History |
| MCKMcKesson Corp | Stock | 5,800 | $4.48M | 1.0% | −7,700−57.0% | Reduced | History |
| CARLCarlsmed, Inc. | COM | 321,912 | $4.31M | 1.0% | +321,912 | New | History |
| KVUEKenvue Inc. | Stock | 265,200 | $4.30M | 1.0% | +265,200 | New | History |
| IMUXImmunic, Inc. | COM | 4,699,411 | $4.14M | 0.9% | −916,400−16.3% | Reduced | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 214,400 | $4.04M | 0.9% | −53,600−20.0% | Reduced | History |
| EXASExact Sciences Corp | COM | 73,600 | $4.03M | 0.9% | −281,400−79.3% | Reduced | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 306,000 | $3.60M | 0.8% | −758,500−71.3% | Reduced | History |
| RGENRepligen Corp | COM | 23,300 | $3.11M | 0.7% | −83,200−78.1% | Reduced | History |
| ACADAcadia Pharmaceuticals Inc | COM | 144,000 | $3.07M | 0.7% | +144,000 | New | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 14,500 | $2.88M | 0.7% | +14,500 | New | History |
| ELVNEnliven Therapeutics, Inc. | COM | 140,300 | $2.87M | 0.7% | +129,000+1,141.6% | Added | History |
| BEAMBeam Therapeutics Inc. | COM | 112,000 | $2.72M | 0.6% | −297,400−72.6% | Reduced | History |
| SCYXScynexis Inc | COM NEW | 3,350,528 | $2.58M | 0.6% | +2,121,618+172.6% | Added | History |
| HQYHealthequity, Inc. | COM | 25,300 | $2.40M | 0.5% | −66,700−72.5% | Reduced | History |
| WVEWave Life Sciences, Inc. | SHS | 297,500 | $2.18M | 0.5% | +297,500 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 53,400 | $2.14M | 0.5% | −54,491−50.5% | Reduced | History |
| AKROAkero Therapeutics, Inc. | COM | 40,500 | $1.92M | 0.4% | −93,500−69.8% | Reduced | History |
| INSMINSMED Inc | COM PAR $.01 | 11,600 | $1.67M | 0.4% | −47,400−80.3% | Reduced | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 134,566 | $880.1K | 0.2% | 00.0% | Unchanged | History |
| IMRXImmuneering Corp | CLASS A COM | 90,900 | $636.3K | 0.1% | +90,900 | New | History |
Sold out since Q2 2025 (25)
Positions held at the end of Q2 2025 that are gone from this filing.
| Security | Class | Shares in Q2 2025 | Value in Q2 2025 | % of portfolio in Q2 2025 | History |
|---|---|---|---|---|---|
| THCTenet Healthcare Corp | COM NEW | 106,000 | $18.7M | 3.7% | History |
| DXCMDexcom Inc | COM | 210,500 | $18.4M | 3.7% | History |
| HNGEHinge Health, Inc. | CL A | 322,344 | $16.7M | 3.3% | History |
| ISRGIntuitive Surgical Inc | COM NEW | 27,100 | $14.7M | 3.0% | History |
| AXSMAxsome Therapeutics, Inc. | COM | 94,500 | $9.86M | 2.0% | History |
| RVMDRevolution Medicines, Inc. | COM | 228,600 | $8.41M | 1.7% | History |
| OMDAOmada Health, Inc. | COM | 390,600 | $7.15M | 1.4% | History |
| HUMHumana Inc | Stock | 27,600 | $6.75M | 1.4% | History |
| OGNOrganon & Co. | Stock | 640,000 | $6.20M | 1.2% | History |
| BBIOBridgeBio Pharma, Inc. | COM | 140,000 | $6.05M | 1.2% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 19,000 | $5.75M | 1.2% | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 154,000 | $5.60M | 1.1% | History |
| DOCSDoximity, Inc. | CL A | 60,000 | $3.68M | 0.7% | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 33,800 | $3.20M | 0.6% | History |
| QUREuniQure N.V. | SHS | 207,000 | $2.89M | 0.6% | History |
| APGEApogee Therapeutics, Inc. | COM | 65,000 | $2.82M | 0.6% | History |
| SLNOSoleno Therapeutics Inc | COM | 32,000 | $2.68M | 0.5% | History |
| CAHCardinal Health Inc | Stock | 15,000 | $2.52M | 0.5% | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 140,000 | $2.44M | 0.5% | History |
| KZRKezar Life Sciences, Inc. | COM | 502,600 | $2.30M | 0.5% | History |
| NTLAIntellia Therapeutics, Inc. | COM | 232,000 | $2.18M | 0.4% | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 39,000 | $1.84M | 0.4% | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 150,000 | $1.40M | 0.3% | History |
| ALTAltimmune, Inc. | COM NEW | 105,000 | $406.4K | 0.1% | History |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | 138,000 | $52.6K | <0.1% | History |